Pronethalol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethanol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Routes | Oral |
| Identifiers | |
| CAS number | 51-02-5 |
| ATC code | None |
| PubChem | CID 4930 |
| ChemSpider | 4761 |
| UNII | XBP4RT1IMQ |
| Chemical data | |
| Formula | C15H19NO |
| Mol. mass | 229.32 g/mol |
| SMILES | eMolecules & PubChem |
Pronethalol (Alderlin, Nethalide) was an early non-selective beta blocker clinical candidate. It was never used clinically due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite.[1]
[edit] See also
[edit] References
- ^ Stapleton MP (1997). "Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology". Tex Heart Inst J 24 (4): 336–42. PMC 325477. PMID 9456487. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=325477.
|
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |

